These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9884829)

  • 21. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium.
    Tripodi MF; Rambaldi A; Sarnataro G; Ragone E; Utili R
    J Antimicrob Chemother; 1999 Nov; 44(5):719-20. PubMed ID: 10552994
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillin-netilmicin synergism against Streptococcus faecalis.
    Korzeniowski OM; Wennersten C; Moellering RC; Sande MA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):430-4. PubMed ID: 122522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
    Tripodi MF; Locatelli A; Adinolfi LE; Andreana A; Utili R
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of gentamicin plus ampicillin on enterococci.
    Lopardo HA
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):137-8. PubMed ID: 11248529
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci.
    Perri MB; Chow JW; Zervos MJ
    Diagn Microbiol Infect Dis; 1993; 17(2):151-5. PubMed ID: 8243036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and antimicrobial susceptibility of clinical isolates of enterococci.
    Guiney M; Urwin G
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):362-6. PubMed ID: 8354304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomally mediated high-level gentamicin resistance in Streptococcus mitis.
    Kaufhold A; Potgieter E
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2740-2. PubMed ID: 8109946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci.
    Watanakunakorn C; Glotzbecker C
    J Antimicrob Chemother; 1978 Nov; 4(6):539-43. PubMed ID: 711651
    [No Abstract]   [Full Text] [Related]  

  • 33. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
    You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J; Perri MB; Thal LA; Donabedian SA; Zervos MJ
    J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bactericidal activity of penicillin-netilmicin and penicillin-gentamicin against enterococci.
    Rahal JJ; Simberkoff MS
    J Antimicrob Chemother; 1986 May; 17(5):585-91. PubMed ID: 3636323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1981 Aug; 20(2):247-51. PubMed ID: 7283421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity among high-level aminoglycoside-resistant enterococci.
    Papaparaskevas J; Vatopoulos A; Tassios PT; Avlami A; Legakis NJ; Kalapothaki V
    J Antimicrob Chemother; 2000 Mar; 45(3):277-83. PubMed ID: 10702545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs.
    Ferrara A; Dos Santos C; Cimbro M
    Chemotherapy; 1996; 42(1):37-46. PubMed ID: 8751265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.